These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 34847503)

  • 1. Stakeholder preferences for supervised consumption site design, staff, and ancillary services: A scoping review of feasibility studies.
    Kryszajtys DT; Xavier J; Rudzinski K; Guta A; Chan Carusone S; Strike CJ
    Drug Alcohol Depend; 2022 Jan; 230():109179. PubMed ID: 34847503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rules and Eligibility Criteria for Supervised Consumption Services Feasibility Studies - A Scoping Review.
    Xavier J; Rudzinski K; Guta A; Carusone SC; Strike C
    Int J Drug Policy; 2021 Feb; 88():103040. PubMed ID: 33220597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A scoping review of qualitative research on barriers and facilitators to the use of supervised consumption services.
    Ivsins A; Warnock A; Small W; Strike C; Kerr T; Bardwell G
    Int J Drug Policy; 2023 Jan; 111():103910. PubMed ID: 36436364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. To what extent do supervised drug consumption services incorporate non-injection routes of administration? A systematic scoping review documenting existing facilities.
    Speed KA; Gehring ND; Launier K; O'Brien D; Campbell S; Hyshka E
    Harm Reduct J; 2020 Oct; 17(1):72. PubMed ID: 33028363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mobile supervised consumption services in Rural British Columbia: lessons learned.
    Mema SC; Frosst G; Bridgeman J; Drake H; Dolman C; Lappalainen L; Corneil T
    Harm Reduct J; 2019 Jan; 16(1):4. PubMed ID: 30634986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "It's just not the same": Exploring PWUD' perceptions of and experiences with drug policy and SCS services change in a Canadian City.
    Greene C; Maier K; Urbanik MM
    Int J Drug Policy; 2023 Jan; 111():103934. PubMed ID: 36549200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Service utilization patterns and characteristics among clients of integrated supervised consumption sites in Toronto, Canada.
    Nassau T; Kolla G; Mason K; Hopkins S; Tookey P; McLean E; Werb D; Scheim A
    Harm Reduct J; 2022 Mar; 19(1):33. PubMed ID: 35351160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The state of science on including inhalation within supervised consumption services: A scoping review of academic and grey literature.
    Gehring ND; Speed KA; Launier K; O'Brien D; Campbell S; Hyshka E
    Int J Drug Policy; 2022 Apr; 102():103589. PubMed ID: 35101668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Another tool in the toolkit"-Perceptions, suggestions, and concerns of emergency service providers about the implementation of a supervised consumption site.
    Perlmutter D; Wettemann C; Fockele CE; Frohe T; Williams W; Holland N; Oliphant-Wells T; Meischke H; van Draanen J
    Int J Drug Policy; 2023 May; 115():104005. PubMed ID: 36972652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "You don't have to squirrel away in a staircase": Patient motivations for attending a novel supervised drug consumption service in acute care.
    Kosteniuk B; Salvalaggio G; McNeil R; Brooks HL; Dong K; Twan S; Brouwer J; Hyshka E
    Int J Drug Policy; 2021 Oct; 96():103275. PubMed ID: 34020865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A qualitative comparison of how people who use drugs' perceptions and experiences of policing affect supervised consumption services access in two cities.
    Urbanik MM; Maier K; Greene C
    Int J Drug Policy; 2022 Jun; 104():103671. PubMed ID: 35413583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Communities are attempting to tackle the crisis': a scoping review on community plans to prevent and reduce opioid-related harms.
    Leece P; Khorasheh T; Paul N; Keller-Olaman S; Massarella S; Caldwell J; Parkinson M; Strike C; Taha S; Penney G; Henderson R; Manson H
    BMJ Open; 2019 Sep; 9(9):e028583. PubMed ID: 31515417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hoots and harm reduction: a qualitative study identifying gaps in overdose prevention among women who smoke drugs.
    Bardwell G; Austin T; Maher L; Boyd J
    Harm Reduct J; 2021 Mar; 18(1):29. PubMed ID: 33678163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation and sustainability of safe consumption sites: a qualitative systematic review and thematic synthesis.
    Yoon GH; Levengood TW; Davoust MJ; Ogden SN; Kral AH; Cahill SR; Bazzi AR
    Harm Reduct J; 2022 Jul; 19(1):73. PubMed ID: 35790994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peer-assisted injection as a harm reduction measure in a supervised consumption service: a qualitative study of client experiences.
    Pijl E; Oosterbroek T; Motz T; Mason E; Hamilton K
    Harm Reduct J; 2021 Jan; 18(1):5. PubMed ID: 33407575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harm Reduction Services in Ottawa: The Culture of Drug Use.
    Haines M; O'Byrne P
    Res Theory Nurs Pract; 2020 May; 34(2):188-202. PubMed ID: 32457123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barriers and facilitators to buprenorphine use for opioid agonist treatment: protocol for a scoping review.
    Leece P; Khorasheh T; Corace K; Strike C; Bayoumi AM; Taha S; Marks E; Pach B; Ahamad K; Grennell E; Holowaty M; Manson H; Straus SE
    BMJ Open; 2019 Dec; 9(12):e032285. PubMed ID: 31843837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peer worker involvement in low-threshold supervised consumption facilities in the context of an overdose epidemic in Vancouver, Canada.
    Kennedy MC; Boyd J; Mayer S; Collins A; Kerr T; McNeil R
    Soc Sci Med; 2019 Mar; 225():60-68. PubMed ID: 30798157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating networked drug checking services in Toronto, Ontario: study protocol and rationale.
    Maghsoudi N; McDonald K; Stefan C; Beriault DR; Mason K; Barnaby L; Altenberg J; MacDonald RD; Caldwell J; Nisenbaum R; Leece P; Watson TM; Tupper KW; Kufner L; Scheim AI; Werb D;
    Harm Reduct J; 2020 Jan; 17(1):9. PubMed ID: 32204713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.